wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q24681743-3D843058-85EA-40E6-9CA5-22D620AC6DFC
Q24681743-3D843058-85EA-40E6-9CA5-22D620AC6DFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24681743-3D843058-85EA-40E6-9CA5-22D620AC6DFC
Sequential ABL kinase inhibitor therapy selects for compound drug-resistant BCR-ABL mutations with altered oncogenic potency
P2860
Q24681743-3D843058-85EA-40E6-9CA5-22D620AC6DFC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q24681743-3D843058-85EA-40E6-9CA5-22D620AC6DFC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3a90ffa90f0f33235216df7d961377e32af67882
P2860
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl.